Global Hemp Group Inc C.GHG

Alternate Symbol(s): GBHPF

Healthcare Biotechnology

Global Hemp Group Inc. is a Canada-based company. The Company is focused on two business segments: Industrial Hemp and Health & Wellness (Biopharma). The Industrial Hemp segment primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. It is also focused on aligning with its hemp agro-industrial zone (HAIZ) strategy to achieve a carbon-negative footprint. Its principal feature of the HAIZ concept is the proximity of the industrial plant to the supply of raw materials and final markets. The Health and Wellness segment is focused on the acquisition of exclusive licensing of patents and intellectual property (IP). It acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms.

CSE:GHG - Post by User

Global Hemp Group Inc

<< Previous

Bullboard Posts

Next >>

Post by bveilleuon Mar 15, 2021 4:31pm

206 Views

Post# 32801100

Exercise of options Michel Lebeuf

Filed 2021-03-15 09:20 Tx date 2021-03-09	$GHG Global Hemp Group Inc.	Lebeuf, Michel 4 - Director of Issuer Direct Ownership	Common Shares Class A 51 - Exercise of options	$27,500 +500,000 vol $0.055 each	500,000
Filed 2021-03-15 09:19 Tx date 2020-05-21	$GHG Global Hemp Group Inc.	Lebeuf, Michel 4 - Director of Issuer Direct Ownership	Common Shares Class A 00 - Opening Balance-Initial SEDI Report
Filed 2021-03-15 09:17 Tx date 2021-03-09	$GHG Global Hemp Group Inc.	Lebeuf, Michel 4 - Director of Issuer Direct Ownership	Options 51 - Exercise of options	-500,000 vol	0